+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmaceutical Services Outsourcing Market Research Report by Service (Auditing & Assessment, Consulting, and Product Design & Development), End-Use, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 245 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5639460
UP TO OFF until Mar 31st 2023
The Global Pharmaceutical Services Outsourcing Market size was estimated at USD 72.66 billion in 2022, USD 77.74 billion in 2023, and is projected to grow at a CAGR of 7.47% to reach USD 129.34 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Pharmaceutical Services Outsourcing Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Pharmaceutical Services Outsourcing Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Pharmaceutical Services Outsourcing Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Pharmaceutical Services Outsourcing Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Pharmaceutical Services Outsourcing Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Service, the market is studied across Auditing & Assessment, Consulting, Product Design & Development, Product Maintenance, Product Testing & Validation, Regulatory Affairs, and Training & Education.
  • Based on End-Use, the market is studied across Biotech and Pharma.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Pharmaceutical Services Outsourcing Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Pharmaceutical Services Outsourcing Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Pharmaceutical Services Outsourcing Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Pharmaceutical Services Outsourcing Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Services Outsourcing Market, including Cambrex Corporation, CareCloud, Inc., Cerner Corporation, Charles River Laboratories International, Inc., Concept Heidelberg GmbH, Eurofins Scientific SE, ICON PLC, Inspired Pharma Training Ltd., IQVIA Inc., Lachman Consultant Services, Inc., NextGen Healthcare, Inc., Parexel International Corporation, Reading Scientific Services Ltd., SGS SA, and The Quantic Group.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pharmaceutical Services Outsourcing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Services Outsourcing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Services Outsourcing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Services Outsourcing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Services Outsourcing Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Services Outsourcing Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Services Outsourcing Market?
Frequently Asked Questions about the Global Pharmaceutical Services Outsourcing Market

What is the estimated value of the Global Pharmaceutical Services Outsourcing Market?

The Global Pharmaceutical Services Outsourcing Market was estimated to be valued at $72.66 Billion in 2022.

What is the growth rate of the Global Pharmaceutical Services Outsourcing Market?

The growth rate of the Global Pharmaceutical Services Outsourcing Market is 7.4%, with an estimated value of $129.34 Billion by 2030.

What is the forecasted size of the Global Pharmaceutical Services Outsourcing Market?

The Global Pharmaceutical Services Outsourcing Market is estimated to be worth $129.34 Billion by 2030.

Who are the key companies in the Global Pharmaceutical Services Outsourcing Market?

Key companies in the Global Pharmaceutical Services Outsourcing Market include Cambrex Corporation, CareCloud, Inc., Cerner Corporation, Charles River Laboratories International, Inc., Concept Heidelberg GmbH, Eurofins Scientific SE, ICON PLC, Inspired Pharma Training Ltd. and Lachman Consultant Services, Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing pharmaceutical expenditure on research and development activities
5.1.1.2. Potential need attributed to cost and time saving in operations and management of a production & research facility
5.1.1.3. Growing demand from small pharmaceuticals and biotechnology companies
5.1.2. Restraints
5.1.2.1. Reduced profit margins owing to robust competition in the market
5.1.3. Opportunities
5.1.3.1. Emerging adoption of machine learning and artificial intelligence coupled with automation in drug development
5.1.3.2. Extensive investment in novel and therapeutic therapies such as regenerative medicine
5.1.4. Challenges
5.1.4.1. Lack of consistency in the pharmaceutical product quality
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Pharmaceutical Services Outsourcing Market, by Service
6.1. Introduction
6.2. Auditing & Assessment
6.3. Consulting
6.4. Product Design & Development
6.5. Product Maintenance
6.6. Product Testing & Validation
6.7. Regulatory Affairs
6.8. Training & Education

7. Pharmaceutical Services Outsourcing Market, by End-Use
7.1. Introduction
7.2. Biotech
7.3. Pharma

8. Americas Pharmaceutical Services Outsourcing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Pharmaceutical Services Outsourcing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Services Outsourcing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Product Portfolio Analysis, By Key Player
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Cambrex Corporation
12.2. CareCloud, Inc.
12.3. Cerner Corporation
12.4. Charles River Laboratories International, Inc.
12.5. Concept Heidelberg GmbH
12.6. Eurofins Scientific SE
12.7. ICON PLC
12.8. Inspired Pharma Training Ltd.
12.9. IQVIA Inc.
12.10. Lachman Consultant Services, Inc.
12.11. NextGen Healthcare, Inc.
12.12. Parexel International Corporation
12.13. Reading Scientific Services Ltd.
12.14. SGS SA
12.15. The Quantic Group

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET DYNAMICS
FIGURE 11. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 14. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET COMPETITIVE STRATEGIC WINDOW, BY SERVICE, 2030
FIGURE 15. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY AUDITING & ASSESSMENT, 2018-2030 (USD BILLION)
FIGURE 16. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD BILLION)
FIGURE 17. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT DESIGN & DEVELOPMENT, 2018-2030 (USD BILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT MAINTENANCE, 2018-2030 (USD BILLION)
FIGURE 19. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT TESTING & VALIDATION, 2018-2030 (USD BILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD BILLION)
FIGURE 21. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TRAINING & EDUCATION, 2018-2030 (USD BILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 23. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USE, 2030
FIGURE 25. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOTECH, 2018-2030 (USD BILLION)
FIGURE 26. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMA, 2018-2030 (USD BILLION)
FIGURE 27. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 28. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 29. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 30. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 31. ARGENTINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 32. BRAZIL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 33. CANADA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 34. MEXICO PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 35. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 36. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 37. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 38. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 39. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 40. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 41. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 42. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 43. AUSTRALIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 44. CHINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 45. INDIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 46. INDONESIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 47. JAPAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 48. MALAYSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 49. PHILIPPINES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 50. SINGAPORE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 51. SOUTH KOREA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 52. TAIWAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 53. THAILAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 54. VIETNAM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 59. DENMARK PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 60. EGYPT PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 61. FINLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 62. FRANCE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 63. GERMANY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 64. ISRAEL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 65. ITALY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 66. NETHERLANDS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 67. NIGERIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 68. NORWAY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 69. POLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 70. QATAR PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 71. RUSSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 72. SAUDI ARABIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 73. SOUTH AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 74. SPAIN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 75. SWEDEN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 76. SWITZERLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 77. TURKEY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 78. UNITED ARAB EMIRATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 79. UNITED KINGDOM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 80. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 81. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 82. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD BILLION)
TABLE 5. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 6. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 7. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY AUDITING & ASSESSMENT, 2018-2030 (USD BILLION)
TABLE 8. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY AUDITING & ASSESSMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 9. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY AUDITING & ASSESSMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 10. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD BILLION)
TABLE 11. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, BY REGION, 2018-2030 (USD BILLION)
TABLE 12. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, BY REGION, 2018-2030 (USD BILLION)
TABLE 13. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT DESIGN & DEVELOPMENT, 2018-2030 (USD BILLION)
TABLE 14. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT DESIGN & DEVELOPMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 15. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT DESIGN & DEVELOPMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 16. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT MAINTENANCE, 2018-2030 (USD BILLION)
TABLE 17. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT MAINTENANCE, BY REGION, 2018-2030 (USD BILLION)
TABLE 18. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT MAINTENANCE, BY REGION, 2018-2030 (USD BILLION)
TABLE 19. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT TESTING & VALIDATION, 2018-2030 (USD BILLION)
TABLE 20. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT TESTING & VALIDATION, BY REGION, 2018-2030 (USD BILLION)
TABLE 21. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT TESTING & VALIDATION, BY REGION, 2018-2030 (USD BILLION)
TABLE 22. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD BILLION)
TABLE 23. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2018-2030 (USD BILLION)
TABLE 24. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2018-2030 (USD BILLION)
TABLE 25. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TRAINING & EDUCATION, 2018-2030 (USD BILLION)
TABLE 26. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2030 (USD BILLION)
TABLE 27. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2030 (USD BILLION)
TABLE 28. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 29. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOTECH, 2018-2030 (USD BILLION)
TABLE 30. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOTECH, BY REGION, 2018-2030 (USD BILLION)
TABLE 31. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOTECH, BY REGION, 2018-2030 (USD BILLION)
TABLE 32. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMA, 2018-2030 (USD BILLION)
TABLE 33. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMA, BY REGION, 2018-2030 (USD BILLION)
TABLE 34. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMA, BY REGION, 2018-2030 (USD BILLION)
TABLE 35. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 36. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 37. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 38. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 39. ARGENTINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 40. ARGENTINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 41. ARGENTINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 42. BRAZIL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 43. BRAZIL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 44. BRAZIL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 45. CANADA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 46. CANADA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 47. CANADA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 48. MEXICO PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 49. MEXICO PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 50. MEXICO PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 51. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 52. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 53. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 54. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 55. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 56. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 57. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 58. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 59. AUSTRALIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 60. AUSTRALIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 61. AUSTRALIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 62. CHINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 63. CHINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 64. CHINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 65. INDIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 66. INDIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 67. INDIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 68. INDONESIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 69. INDONESIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 70. INDONESIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 71. JAPAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 72. JAPAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 73. JAPAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 74. MALAYSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 75. MALAYSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 76. MALAYSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 77. PHILIPPINES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 78. PHILIPPINES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 79. PHILIPPINES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 80. SINGAPORE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 81. SINGAPORE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 82. SINGAPORE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 83. SOUTH KOREA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 84. SOUTH KOREA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 85. SOUTH KOREA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 86. TAIWAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 87. TAIWAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 88. TAIWAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 89. THAILAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 90. THAILAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 91. THAILAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 92. VIETNAM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 93. VIETNAM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 94. VIETNAM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 99. DENMARK PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 100. DENMARK PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 101. DENMARK PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 102. EGYPT PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 103. EGYPT PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 104. EGYPT PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 105. FINLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 106. FINLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 107. FINLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 108. FRANCE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 109. FRANCE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 110. FRANCE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 111. GERMANY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 112. GERMANY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 113. GERMANY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 114. ISRAEL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 115. ISRAEL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 116. ISRAEL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 117. ITALY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 118. ITALY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 119. ITALY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 120. NETHERLANDS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 121. NETHERLANDS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 122. NETHERLANDS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 123. NIGERIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 124. NIGERIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 125. NIGERIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 126. NORWAY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 127. NORWAY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 128. NORWAY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 129. POLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 130. POLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 131. POLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 132. QATAR PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 133. QATAR PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 134. QATAR PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 135. RUSSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 136. RUSSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 137. RUSSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 138. SAUDI ARABIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 139. SAUDI ARABIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 140. SAUDI ARABIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 141. SOUTH AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 142. SOUTH AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 143. SOUTH AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 144. SPAIN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 145. SPAIN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 146. SPAIN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 147. SWEDEN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 148. SWEDEN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 149. SWEDEN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 150. SWITZERLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 151. SWITZERLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 152. SWITZERLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 153. TURKEY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 154. TURKEY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 155. TURKEY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 156. UNITED ARAB EMIRATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 157. UNITED ARAB EMIRATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 158. UNITED ARAB EMIRATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 159. UNITED KINGDOM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 160. UNITED KINGDOM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 161. UNITED KINGDOM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD BILLION)
TABLE 162. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 163. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 164. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 165. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET RANKING, BY KEY PLAYER, 2022
TABLE 166. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 167. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 168. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET MERGER & ACQUISITION
TABLE 169. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 170. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 171. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET INVESTMENT & FUNDING
TABLE 172. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 173. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET: LICENSE & PRICING

Companies Mentioned

  • Cambrex Corporation
  • CareCloud, Inc.
  • Cerner Corporation
  • Charles River Laboratories International, Inc.
  • Concept Heidelberg GmbH
  • Eurofins Scientific SE
  • ICON PLC
  • Inspired Pharma Training Ltd.
  • IQVIA Inc.
  • Lachman Consultant Services, Inc.
  • NextGen Healthcare, Inc.
  • Parexel International Corporation
  • Reading Scientific Services Ltd.
  • SGS SA
  • The Quantic Group

Methodology

Loading
LOADING...